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Previewsappetite suppressants and/or prevent
excessive food intake in people quitting
cigarette smoking. This approach is anal-
ogous to the use of varenicline (Mihalak
et al., 2006), a nicotinic partial agonist
based on the structure of cytisine, which
has been approved by the U.S. Food and
Drug Administration for use as a smoking
cessation aid. Although varenicline is
morepotent ona4b2 andmore efficacious
on a7, respectively, than on a3b4 nicotinic
receptors, development of novel selective
compounds for this latter receptor
subtype could potentially act as a safe
stimulator of POMC neurons to aid re-
duced food intake without causing thenegative side effects observed with some
nicotinic drugs, such as cardiovascular
stimulation and psychomotor depression.
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Defining the molecular events that precipitate multisystem decline is an important component of aging
research. In this issue, Jin et al. (2011) show that increased expression of the histone demethylase, utx-1,
causes genome-wide decreases in histone H3K27 trimethylation, which includes the insulin/IGF-1 signaling
(IIS) pathway that promotes aging.Complex systems rely on solid infrastruc-
ture. Information has to be accessible,
communicable, and translated into effi-
cient operational output. Biological aging
of a complex system (a human being or
even a C. elegans worm) may be a
progressive failure at each of these levels,
from flawed cellular record keeping to
breakdown of information transmission
and an inability to mount a cellular
response to maintain function or adapt
to change (Figure 1). In this issue, Jin
et al. identify a mechanism by which infor-
mation, in the form of epigenetic marks, is
lost with age in C. elegans and propose
that this record-keeping failure drives
signal-transduction pathways in amanner
that promotes aging (Jin et al., 2011).
Eukaryotic genomes are repetitively
packaged into chromatin by nucleosomes
and nuclear architecture is regulated by
specific covalent posttranslational modifi-cations (PTMs) of histone proteins, the
basic nucleosomal components (Kouzar-
ides, 2007). Local histone PTMs direct
inheritance and propagation of the chro-
matin states, which control cell-type
specific transcriptional responses. The
mechanisms responsible for cell-type
specific chromatin establishment and
maintenance in dividing cells, hence
epigenetic inheritance of chromatin state,
still remains largely enigmatic and is
thought to rely upon a highly coordinated
interplay between enzymes that catalyze
(writers), and remove (erasers) histone
PTMs, as well as, the proteins that recog-
nize and bind to those modifications
(readers) (Yun et al., 2011). Tightly
controlled equilibria between these
molecular players may be especially rele-
vant during aging, where chromatin dete-
rioration is a prime suspect in impaired
cellular function.It is believed that chromatin structure
not only plays an important regulatory
role in aging, but also that multiple
aging-related signaling pathways in turn
have complex interplay with chromatin,
both influencing and being influenced by
PTMs. For instance, methylation of
histone lysine residues is dynamically
regulated by the opposing activities of
substrate-specific histone lysine methyl-
transferases (writers) and demethylases
(erasers) (Allis et al., 2007). These
enzymes have recently been shown to
modulate germ-line immortality (LSD1)
and longevity (ASH1) (Katz et al., 2009;
Jin et al., 2011 and references therein).
Jin et al. demonstrates an aging role
for another histone demethylase, UTX-1,
in C. elegans. UTX-1/KMT6A demethy-
lase activity along with JMJD3/KDM6B
is critical for removal of transcriptionally
repressive trimetylation on lysine 27 of4, August 3, 2011 ª2011 Elsevier Inc. 147
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Figure 1. Loss of Nuclear Organization with Age through Elevated Expression of a Histone
Demethylase
Establishment of the epigenetic state of the genome occurs during development and is important for coor-
dinating cellular and organismal functions. Findings by Jin et al. (2011) show that themaintenance of these
epigenetic patterns is crucial for offsetting aging in C. elegans.
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Previewshistone H3 (H3K27me3) (Agger et al.,
2007).
H3K27me3, a silencingmark, is thought
to be critical for establishment and main-
tenance of both constitutive and faculta-
tive heterochromatin, two chromatin
structures that are strictly guarded within
the cells since they dictate developmental
and cell-type specificity for transcription,
imprinting, X chromosome inactivation,
and establishment of bivalent domains
(Jin et al., 2011 and references therein).
They also suppress retrotransposal el-
ements and protect the integrity of telo-
mere- and centromere-proximal regions.
H3K27me3 by the writer ESC-E(Z)/EED-
EZH2 member of multisubunit complex
PRC2, facilitates binding of the reader
Polycomb (PC), a core component of the
PRC1 complex. The latter complex
compacts chromatin through an addi-
tional cascade of chromatin—specific
modifications, such as monoubiquityla-
tion of histone H2A. Loss of H3K27me3
occurs in cells from Hutchinson-Gilford
progeria syndrome (HGPS) patients
(Shumaker et al., 2006), a rare and fatal
human pathology resembling aspects of
premature aging. Among other character-
istics, HGPS cells exhibit severe nuclear-
architecture defectsmarked by disorgani-
zation of the nuclear lamina and loss of
heterochromatin (Burtner and Kennedy,
2010). The HGPS report findings promp-
ted Jin et al. (2011) to search for methyl-
transferases and demethylases that
change in expression with age among
human brain samples (Jin et al., 2011
and references therein). One demethylase
was found to rise in expression, prompt-
ing an examination of the C. elegans
ortholog, utx-1. Strikingly, UTX-1 activity
goes up as C. elegans age along with148 Cell Metabolism 14, August 3, 2011 ª201a concomitant decrease in H3K27me3.
This is important to longevity since
genetic approaches to reduce utx-1
expression confer a significant increase
in life span. These worms are also more
resistant to a variety of stress conditions
linked to aging.
Epistasis studies of utx-1 showed that
reduced UTX-1 promotes life-span exten-
sion in a daf-16-dependent manner. Daf-
16 encodes the FOXO transcription factor
downstream of the insulin/IGF pathway,
and its activity is required for life-span
extension through reduced expression of
the insulin IGF receptor, daf-2 (Kenyon,
2010). What makes this report important
is that Jin et al. (2011) were able to work
out a mechanism whereby increased
UTX-1 activity and an associated loss of
H3K27me3 lead to life-span extension.
They show that loss of this histone PTM
at the Igf1r/daf-2 gene, leading to
enhanced transcription of daf-2 and
elevated insulin signaling. This study
therefore links altered epigenetic control
with age to deregulation of the major
signal transduction pathway (IIS) linked
to aging. It also raises key questions,
such as what events lead to enhanced
UTX-1 activity. Altered H3K27me3 may
be a signal of cellular stress with
increased transcription of daf-2 being
part of the response pathway. Identifying
the molecular events that trigger this
pathway may change our perspective on
how altered insulin/IGF signaling contrib-
utes to the aging process.
This study also suggests that a UTX-1-
regulated chromatin signature might be
evolutionarily conserved from inverte-
brates to mammals. The next challenge
is to identify whether or not UTX-1-
dependent H3K27me3 loss (1) impacts1 Elsevier Inc.establishment and maintenance of facul-
tative and constitutive heterochromatin,
(2) promotes antagonistic to PcG-medi-
ated silencing acetylation of H3K27, and
(3) extends to neighboring nucleosomes
or affects nucleosome positioning. Future
investigations should also clarify whether
an increase in UTX-1 activity leads to
aging-related histone eviction (Feser
et al., 2010), recycling, and alterations in
chromatin dynamics controlled by coordi-
nated action of histone chaperones.
Importantly, the experimental evidence
presented by Jin et al. (2011) suggests
the possibility of ultimately slowing, or
even reversing, aging through resetting
epigenetic pathways that go awry as we
get old. Reconstruction of the blueprints
of molecular interactions betweenwriters,
erasers, readers, and the PTMs they
create may permit the preservation of
infrastructure of nuclear architecture.
Such blueprints are in demand as
researchers aim to realize the centuries
long dreamof finding a ‘‘fountain of youth’’
to enjoy old age largely free of disabilities.
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